AJANTA PHARMA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,215 INR | +0.13% |
|
+5.93% | +6.33% |
| 04-26 | Ajanta Pharma Limited?s Board intends to launch an Equity Buyback on May 2, 2024. | CI |
| 02-02 | Ajanta Pharma Posts Gains in Fiscal Q3 Consolidated Net Profit | MT |
Chart calendar Ajanta Pharma Limited
7d95c87fa467ded9e.UJsau6DSJ5wdgxGPjDJKWIDG3H0nJrj7ptafdZkpdaM.Fv9e0_mNSPZn2ynV7wYFPuOkhTxNV-GV0eDQFuFsIssp3lbj1YpfyUnqSA~00fd61191da4842fbc4c9c29f698fe25
Upcoming events on Ajanta Pharma Limited
Past events on Ajanta Pharma Limited
| Today | Q4 2024 Earnings Release (Projected) |
| 2024-02-07 | Ex-dividend day for dividende intermédiaire |
| 2024-01-31 06:30 | Q3 2024 Earnings Call |
| 2024-01-31 05:42 | Q3 2024 Earnings Release |
| 2023-10-31 06:30 | Q2 2024 Earnings Call |
| 2023-10-31 04:45 | Q2 2024 Earnings Release |
| 2023-08-03 | Ex-dividend day for extraordinary dividend |
| 2023-08-03 | Ex-dividend day for dividende intermédiaire |
| 2023-07-27 06:30 | Q1 2024 Earnings Call |
| 2023-07-27 06:29 | Q1 2024 Earnings Release |
| 2023-07-18 01:30 | Annual General Meeting |
| 2023-05-05 06:30 | Q4 2023 Earnings Call |
| 2023-05-05 06:16 | Q4 2023 Earnings Release |
| 2023-02-01 05:39 | Q3 2023 Earnings Release |
| 2023-02-01 05:30 | Q3 2023 Earnings Call |
| 2022-11-10 | Ex-dividend day for dividende intermédiaire |
| 2022-11-03 07:30 | Interim 2023 Earnings Call |
| 2022-11-02 | Interim 2023 Earnings Release |
| 2022-08-04 01:30 | Annual General Meeting |
| 2022-07-28 07:30 | Q1 2023 Earnings Call |
Past dividends on Ajanta Pharma Limited
| 2024-02-07 | Interim Payment 26 INR |
| 2023-08-03 | Interim Payment 10 INR |
| 2023-08-03 | Bonus Payment 15 INR |
| 2022-11-10 | Interim Payment 7 INR |
| 2021-11-08 | Interim Payment 9.5 INR |
| 2020-11-11 | Interim Payment 9.5 INR |
| 2019-11-14 | Interim Payment 13 INR |
| 2018-11-08 | Interim Payment 9 INR |
| 2017-03-22 | Interim Payment 7 INR |
| 2016-11-06 | Interim Payment 6 INR |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 20 554 21 125 -2.7% | 25 879 25 044 3.33% | 29 157 28 465 2.43% | 33 410 32 671 2.26% | 37 426 38 048 -1.63% | 42 008 |
|
EBITDA Million INR | Released Forecast Spread | 5 664 5 668 -0.07% | 6 830 7 125 -4.13% | 9 990 9 329 7.08% | 9 290 9 592 -3.15% | 7 830 8 179 -4.26% | 11 412 |
|
EBIT Million INR | Released Forecast Spread | 5 154 5 363 -3.89% | 5 876 5 977 -1.69% | 9 344 8 054 16.03% | 8 040 8 565 -6.12% | 6 525 7 164 -8.93% | 10 159 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 5 143 5 184 -0.79% | 6 640 6 217 6.8% | 9 002 8 452 6.51% | 9 095 9 276 -1.95% | 7 453 8 071 -7.66% | 10 935 |
|
Net income Million INR | Released Forecast Spread | 3 870 3 857 0.32% | 4 677 4 423 5.74% | 6 539 6 213 5.25% | 7 127 7 274 -2.03% | 5 880 6 382 -7.87% | 8 080 |
|
EPS INR | Released Forecast Spread | 29,3 31,0 -5.51% | 35,7 33,9 5.39% | 50,1 47,2 6.08% | 55,0 56,1 -2.06% | 45,9 49,6 -7.43% | 63,5 |
| Announcement Date | 30/04/19 | 20/05/20 | 30/04/21 | 10/05/22 | 05/05/23 | - |
Quarterly results
| Fiscal Period | March | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 7 594 7 350 3.31% | 7 480 7 545 -0.87% | 8 848 7 812 13.26% | 8 379 8 296 1% | 8 703 8 037 8.28% | 9 509 8 280 14.84% | 9 381 9 426 -0.48% | 9 718 9 271 4.82% | 8 818 9 447 -6.65% | 10 210 9 907 3.06% | 10 248 | 10 527 | 10 217 |
|
EBITDA Million INR | Released Forecast Spread | 2 590 2 179 18.88% | 2 200 2 514 -12.48% | 2 630 2 367 11.12% | 2 400 2 397 0.15% | 2 070 2 213 -6.45% | 2 220 2 115 4.96% | 1 960 2 373 -17.42% | 2 070 2 202 -6% | 1 490 2 077 -28.26% | 2 710 2 135 26.96% | 2 588 | 2 818 | 2 620 |
|
EBIT Million INR | Released Forecast Spread | 2 339 1 760 32.88% | 1 893 2 175 -12.95% | 2 313 2 034 13.71% | 2 079 2 014 3.21% | 1 755 1 860 -5.63% | 1 900 1 726 10.07% | 1 636 1 975 -17.14% | 1 363 1 807 -24.6% | 1 164 1 544 -24.64% | 2 381 2 002 18.95% | 2 406 | 2 368 | 2 251 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 2 288 1 771 29.18% | 2 205 2 193 0.52% | 2 604 2 071 25.75% | 2 309 2 104 9.76% | 1 977 1 830 8.02% | 2 219 1 896 17.01% | 2 030 2 164 -6.19% | 1 683 2 123 -20.69% | 1 521 1 865 -18.47% | 2 690 2 140 25.72% | 2 527 | 2 426 | 2 746 |
|
Net income Million INR | Released Forecast Spread | 1 593 1 454 9.53% | 1 738 1 650 5.31% | 1 959 1 608 21.87% | 1 918 1 662 15.39% | 1 512 1 565 -3.36% | 1 746 1 519 14.93% | 1 566 1 772 -11.6% | 1 345 1 687 -20.27% | 1 223 1 594 -23.28% | 2 081 1 723 20.81% | 1 959 | 2 053 | 1 905 |
|
EPS INR | Released Forecast Spread | 12,3 12,2 0.55% | 13,4 13,3 0.4% | 15,1 10,6 42.39% | 11,8 12,4 -4.84% | 12,2 13,7 -10.8% | 10,5 12,9 -18.29% | 9,54 13,9 -31.37% | 10,3 | 15,8 | 12,0 | |||
| Announcement Date | 30/04/21 | 29/07/21 | 29/10/21 | 31/01/22 | 10/05/22 | 28/07/22 | 03/11/22 | 01/02/23 | 05/05/23 | 27/07/23 | - | - | - |
More events
Past sector events for Ajanta Pharma Limited
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AJANTPHARM Stock
- Calendar Ajanta Pharma Limited
